文献速递慢性肾脏病肾血管病与高血压

筛查慢性肾脏病以改善非糖尿病高血压退伍军人的照护流程:一项实用性整群随机试验

Screening for CKD To Improve Processes of Care among Nondiabetic Veterans with Hypertension: A Pragmatic Cluster-Randomized Trial.
PubMed 文献 · Clin J Am Soc Nephrol · 2020-01-01

本研究为一项实用性整群随机试验,纳入1819名非糖尿病高血压退伍军人,随机分为三组:筛查+教育、筛查+教育+药师共管、常规护理。主要临床结局为1年血压变化,结果显示三组间无显著差异(P=0.49)。干预组中筛查完成率69%,新诊断CKD占21%。因预约识别能力有限,组间CKD检测率差异不足,无法确定筛查是否改善临床结局。

要点

  • 实用性设计使识别、入组和干预实施高效。
  • 干预组中43%被识别可筛查,69%完成检测,21%新诊断CKD。
  • 1年收缩压变化三组间无显著差异(P=0.49)。

核心结论

  • 实用性设计使识别、入组和干预实施高效,但因预约识别能力有限,组间CKD检测率差异不足,无法确定筛查是否改善临床结局。

研究设计与样本

  • 实用性整群随机试验,纳入1819名非糖尿病高血压退伍军人,随机分为41个集群,分三组:筛查+教育、筛查+教育+药师共管、常规护理。

主要发现

  • 中位年龄68岁,55%为白人,1658人(91%)既往有肌酐检测,仅172人(9%)有尿白蛋白/肌酐比值,83人(5%)有胱抑素C检测。
  • 干预组中527/1215人(43%)被识别有 upcoming 预约可进行CKD筛查,其中367人(69%)完成检测,77人(21%)新诊断CKD。
  • 1年收缩压变化:常规护理组-1 mmHg(IQR -11 to 11),筛查+教育组-2 mmHg(-11 to 11),筛查+教育+药师组-2 mmHg(-13 to 10),P=0.49。
  • 意向性分析中次要结局无显著差异;按治疗分析中,干预组启动RAS抑制剂比例更高(15%和12% vs 7%,P=0.01),启动利尿剂比例更高(9%和12% vs 4%,P=0.03)。

临床怎么用

  • 在非糖尿病高血压患者中,基于电子健康记录的CKD筛查可行性中等,但需提高预约识别能力以增加检测率。

局限性

  • 预约识别能力有限导致组间CKD检测率差异不足,无法确定筛查对临床结局的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: We conducted a pilot, pragmatic, cluster-randomized trial to evaluate feasibility and preliminary effectiveness of screening for CKD using a triple-marker approach (creatinine, cystatin C, and albumin/creatinine ratio), followed by education and guidance, to improve care of hypertensive veterans in primary care. We used the electronic health record for identification, enrollment, intervention delivery, and outcome ascertainment. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We randomized 1819 veterans without diabetes but with hypertension (41 clusters) into three arms: (1) CKD screening followed by patient and provider education; (2) screening, education, plus pharmacist comanagement; or (3) usual care. The primary clinical outcome was BP change over 1 year. Implementation and process measures included proportion screened; CKD detection rate; and total and new use of renin-angiotensin system inhibitors, nonsteroidal anti-inflammatory drugs, and diuretics. RESULTS: Median age was 68 years, 55% were white, 1658 (91%) had a prior creatinine measure, but only 172 (9%) had prior urine albumin/creatinine ratio, and 83 (5%) had a prior cystatin C measure. Among those in the intervention, 527 of 1215 (43%) were identified with upcoming appointments to have CKD screening. Of these, 367 (69%) completed testing. Among those tested, 77 (21%) persons had newly diagnosed CKD. After 1 year, change in systolic BP was -1 mm Hg (interquartile range, -11 to 11) in usual care, -2 mm Hg (-11 to 11) in the screen-educate arm, and -2 mm Hg (-13 to 10) in the screen-educate plus pharmacist arm; P=0.49. There were no significant differences in secondary outcomes in intention-to-treat analyses. In as-treated analyses, higher proportions of participants in the intervention arms initiated a renin-angiotensin system inhibitor (15% and 12% versus 7% in usual care, P=0.01) or diuretic (9% and 12% versus 4%, P=0.03). CONCLUSIONS: The pragmatic design made identification, enrollment, and intervention delivery highly efficient. The limited ability to identify appointments resulted in inadequate between-arm differences in CKD testing rates to determine whether screening improves clinical outcomes.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Peralta CA, Frigaard M, Rolon L, et al. Screening for CKD To Improve Processes of Care among Nondiabetic Veterans with Hypertension: A Pragmatic Cluster-Randomized Trial. Clin J Am Soc Nephrol. 2020. PMID: 32034070. doi:10.2215/CJN.05050419

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。